|
NL300886A
(da)
*
|
1962-11-23 |
|
|
|
|
US3524851A
(en)
*
|
1966-10-21 |
1970-08-18 |
Merck & Co Inc |
1-phenoxy-3-morpholino alkylamino-2-propanols
|
|
US4036988A
(en)
*
|
1967-02-06 |
1977-07-19 |
Boehringer Ingelheim G.M.B.H. |
Therapeutic compositions and method
|
|
GB1211589A
(en)
*
|
1968-08-06 |
1970-11-11 |
Ici Ltd |
Enantiomer isolation process
|
|
US3534084A
(en)
*
|
1968-10-16 |
1970-10-13 |
Squibb & Sons Inc |
Adamantylamino-naphthyloxypropanols and related compounds
|
|
US4360464A
(en)
*
|
1969-11-28 |
1982-11-23 |
Teikoku Hormone Mfg. Co. Ltd. |
Process for production of 1-aryloxy-aminopropane derivatives
|
|
US3758583A
(en)
*
|
1971-01-21 |
1973-09-11 |
Syntex Corp |
2-(2-hydroxy-3-aminopropyl-1-yloxy)-1,6-dilfuoro-and-1,6-methano-{8 10{9 annulenes and the salts thereof
|
|
US3998874A
(en)
*
|
1971-03-23 |
1976-12-21 |
Gist-Brocades N.V. |
Phenylene di-ethers
|
|
US3996284A
(en)
*
|
1971-03-23 |
1976-12-07 |
Wijbe Thomas Nauta |
Naphthyl and tetrahydronaphthyl di-ethers
|
|
BE790165A
(fr)
*
|
1971-12-14 |
1973-02-15 |
Parke Davis & Co |
Nouveaux aminoalcanols et procede pour les preparer
|
|
GB1458392A
(en)
*
|
1973-11-09 |
1976-12-15 |
Ici Ltd |
Optically-active 1-aryloxy-2,3-epoxypropane derivatives
|
|
US4051186A
(en)
*
|
1974-06-20 |
1977-09-27 |
The Regents Of The University Of California |
Amino-propranolol
|
|
US4379167A
(en)
*
|
1974-10-25 |
1983-04-05 |
A. H. Robins Company, Inc. |
1-Aryloxy-4-amino-2-butanols and the pharmaceutical use thereof
|
|
US4071552A
(en)
*
|
1976-05-19 |
1978-01-31 |
Ayerst Mckenna And Harrison Ltd. |
Aryloxy aminobutanols, their preparation and use thereof
|
|
US4235919A
(en)
*
|
1977-07-21 |
1980-11-25 |
Sandoz Ltd. |
1-(Indol-4-yloxy)-3-(2-substituted amino)-2-propanols and pharmaceutical use thereof
|
|
US4294966A
(en)
*
|
1978-07-28 |
1981-10-13 |
Ciba-Geigy Corporation |
Process for inverting the configuration in optically active compounds
|
|
GB2119366B
(en)
*
|
1979-03-01 |
1984-04-11 |
Siemens Spa Italiana |
The levorotatory isomer of moprolol and pharmaceutical compositions thereof
|
|
IT1113029B
(it)
*
|
1979-03-01 |
1986-01-20 |
Simes |
Processo per la separazione dei due isomeri ottici del moprololo e composizioni farmaceutiche dell'antipodo levogiro
|
|
DE2943406A1
(de)
*
|
1979-10-26 |
1981-05-07 |
Basf Ag, 6700 Ludwigshafen |
Aminoderivate des 2-methyl-5-(2-hydroxystyryl)-1,3,4-thiadiazols
|
|
MC1357A1
(fr)
*
|
1979-12-07 |
1981-08-10 |
Hoffmann La Roche |
Derives de 2,3-indoledione
|
|
CA1156661A
(en)
*
|
1980-02-25 |
1983-11-08 |
Hoffmann-La Roche Limited |
Phenoxy-aminopropanol derivatives
|
|
JPS56142262A
(en)
|
1980-04-08 |
1981-11-06 |
Nippon Shinyaku Co Ltd |
Piperazine derivative
|
|
US4472427A
(en)
*
|
1980-12-23 |
1984-09-18 |
Merck & Co., Inc. |
(Aralkylamino-2-OR-propoxy)heterocyclic compounds
|
|
FR2507181A1
(fr)
|
1981-06-05 |
1982-12-10 |
Sanofi Sa |
Nouveaux ethers de phenol actifs sur le systeme cardiovasculaire, leur procede de preparation et leur utilisation dans des medicaments
|
|
US4652681A
(en)
*
|
1982-04-15 |
1987-03-24 |
Drug Science Foundation |
Aminoalkoxy derivatives of propranolol for immunoassay applications
|
|
US4897355A
(en)
*
|
1985-01-07 |
1990-01-30 |
Syntex (U.S.A.) Inc. |
N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US5545412A
(en)
*
|
1985-01-07 |
1996-08-13 |
Syntex (U.S.A.) Inc. |
N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor
|
|
US5116867A
(en)
*
|
1989-06-30 |
1992-05-26 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
D-propranolol as a selective adenosine antagonist
|
|
US5488064A
(en)
*
|
1994-05-02 |
1996-01-30 |
Bristol-Myers Squibb Company |
Benzo 1,3 dioxole derivatives
|
|
AU2003208170B2
(en)
*
|
2002-02-28 |
2006-11-23 |
Birseck Pty Ltd |
Treatment of effect of chemicals with their ultradilute stereoisomers
|
|
ES2362998T3
(es)
|
2002-08-19 |
2011-07-18 |
Pfizer Inc. |
Terapia de combinación para enfermedades hiperproliferativas.
|
|
US20060063803A1
(en)
*
|
2004-09-23 |
2006-03-23 |
Pfizer Inc |
4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
|
|
GT200600381A
(es)
|
2005-08-25 |
2007-03-28 |
|
Compuestos organicos
|
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
|
US7888376B2
(en)
|
2005-11-23 |
2011-02-15 |
Bristol-Myers Squibb Company |
Heterocyclic CETP inhibitors
|
|
US8404896B2
(en)
|
2006-12-01 |
2013-03-26 |
Bristol-Myers Squibb Company |
N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
|
|
AU2014255381A1
(en)
|
2013-04-17 |
2015-10-08 |
Pfizer Inc. |
N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
|
|
WO2016055901A1
(en)
|
2014-10-08 |
2016-04-14 |
Pfizer Inc. |
Substituted amide compounds
|
|
MX2021008533A
(es)
|
2019-01-18 |
2021-08-19 |
Astrazeneca Ab |
Inhibidores de la pcsk9 y metodos de uso de los mismos.
|